Literature DB >> 11348695

Rubella eradication.

S A Plotkin1.   

Abstract

The virulence of rubella virus for the fetus was fully defined between 1963 and 1965 when an epidemic of rubella occurred in Europe and the US, followed by a wave of damaged babies. Attenuated live virus vaccines were developed in our and other laboratories and their use has already considerably changed the epidemiology of rubella. Nevertheless, only about half of the world's countries vaccinate against rubella. We argue for the combination of rubella vaccine with measles vaccine in all campaigns for the control of measles, and will discuss the strategies by which congenital rubella syndrome could be eradicated at little additional cost.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11348695     DOI： 10.1016/s0264-410x(01)00073-1

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


  24 in total

1.  Evaluation of three immunoassays used for detection of anti-rubella virus immunoglobulin M antibodies.

Authors:  Wayne Dimech; Lena Panagiotopoulos; Joan Marler; Nicolas Laven; Susan Leeson; Elizabeth M Dax
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

2.  Evaluation of eight anti-rubella virus immunoglobulin g immunoassays that report results in international units per milliliter.

Authors:  Wayne Dimech; Lena Panagiotopoulos; Barbara Francis; Nicholas Laven; Joan Marler; David Dickeson; Tony Panayotou; Kim Wilson; Robyn Wootten; Elizabeth M Dax
Journal:  J Clin Microbiol       Date:  2008-04-23       Impact factor: 5.948

3.  Relationship between HLA polymorphisms and gamma interferon and interleukin-10 cytokine production in healthy individuals after rubella vaccination.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Jenna E Ryan; Neelam Dhiman; Robert A Vierkant; Gregory A Poland
Journal:  Clin Vaccine Immunol       Date:  2007-01-10

4.  Seroprevalence and durability of rubella virus antibodies in a highly immunized population.

Authors:  Stephen N Crooke; Iana H Haralambieva; Diane E Grill; Inna G Ovsyannikova; Richard B Kennedy; Gregory A Poland
Journal:  Vaccine       Date:  2019-05-21       Impact factor: 3.641

5.  Sero-surveillance to assess rubella susceptibility and assessment of immunogenicity and reactogenicity of rubella vaccine in Indian girls aged 18-24 years.

Authors:  Deepak S Phalgune; Rajiv C Yervadekar; Hitt J Sharma; Rajeev M Dhere; Sameer S Parekh; Alka O Chandak; Abhijeet A Safai; Sunil D Shewale
Journal:  Hum Vaccin Immunother       Date:  2014-11-21       Impact factor: 3.452

Review 6.  Zika virus - reigniting the TORCH.

Authors:  Carolyn B Coyne; Helen M Lazear
Journal:  Nat Rev Microbiol       Date:  2016-08-30       Impact factor: 60.633

7.  Comparison of rubella seroepidemiology in 17 countries: progress towards international disease control targets.

Authors:  Anthony Nardone; Annedore Tischer; Nick Andrews; Jo Backhouse; Heidi Theeten; Nina Gatcheva; Marios Zarvou; Bohumir Kriz; Richard G Pebody; Kalman Bartha; Darina O'Flanagan; Dani Cohen; Arnis Duks; Algirdas Griskevicius; Joel Mossong; Christopher Barbara; Adrianna Pistol; Margareta Slaciková; Katarina Prosenc; Kari Johansen; Elizabeth Miller
Journal:  Bull World Health Organ       Date:  2008-02       Impact factor: 9.408

8.  Durability of humoral immune responses to rubella following MMR vaccination.

Authors:  Stephen N Crooke; Marguerite M Riggenbach; Inna G Ovsyannikova; Nathaniel D Warner; Min-Hsin Chen; Lijuan Hao; Joseph P Icenogle; Gregory A Poland; Richard B Kennedy
Journal:  Vaccine       Date:  2020-11-12       Impact factor: 3.641

9.  Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children.

Authors:  Inna G Ovsyannikova; Hannah M Salk; Beth R Larrabee; V Shane Pankratz; Gregory A Poland
Journal:  Immunogenetics       Date:  2015-09-02       Impact factor: 2.846

10.  Analysis of gene expression in fetal and adult cells infected with rubella virus.

Authors:  Maria Pilar Adamo; Marta Zapata; Teryl K Frey
Journal:  Virology       Date:  2007-10-24       Impact factor: 3.616
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.